Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > CG Oncology IPO Today

<< Previous

Bullboard Posts

Next >>

Comment by gebremeskelon Jan 25, 2024 10:01pm

143 Views

Post# 35846351

RE:RE:RE:CG Oncology IPO Today

We may need BTD to get a licensing deal. How would a prospective partner be sure they can trust our numbers without verification by the FDA?

Mikee3003 wrote: I will take a licensing deal over BTD. I'm convinced that BTD alone won't lift the stock as the vulture shylocks will still have us locked in their sights and the manipulation will continue until we have solid means of financing.

Today's action on CG Oncology's IPO is depressing! How can anyone argue that we need new direction from our leadership!

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program